HC Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $203K | Buy |
|
|||||
|
2024
Q2 | $226K | Sell |
|
|||||
|
2024
Q1 | $304K | Buy |
|
|||||
|
2023
Q4 | $270K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $225K | Sell |
|
|||||
|
2023
Q1 | $212K | Sell |
|
|||||
|
2022
Q4 | $215K | Sell |
|
|||||
|
2022
Q3 | $3.52M | Buy |
|
|||||
|
2022
Q2 | $452K | Buy |
|
|||||
|
2022
Q1 | $457K | Sell |
|
|||||
|
2021
Q4 | $643K | Buy |
|
|||||
|
2021
Q3 | $644K | Buy |
|
|||||
|
2021
Q2 | $924K | Buy |
|
|||||
|
2021
Q1 | $564K | Buy |
|
|||||
|
2020
Q4 | $646K | Buy |
|
|||||
|
2020
Q3 | $320K | Buy |
|
|||||
|
2020
Q2 | $269K | Buy |
|